Post-transcriptional regulation of gene expression in the plasminogen activation system

Biological Chemistry

Volumn 383, Issue 1, 2002, Pages 47-53

  Montuori, Nuzia ^a   Rossi, Guido ^a   Ragno, Pia ^a  

^a CNR   (Italy)

Author keywords

mRNA stability; PAl 1; PAl 2; Post transcriptional regulation; uPA; uPAR

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; UROKINASE; UROKINASE RECEPTOR; CELL SURFACE RECEPTOR; MESSENGER RNA; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR, UROKINASE RECEPTORS;

ANIMAL CELL; CELL INTERACTION; CELL INVASION; CELL MIGRATION; COMPLEX FORMATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; TRANSCRIPTION REGULATION; ANIMAL; BIOSYNTHESIS; GENETICS; METABOLISM; PHYSIOLOGY; RNA STABILITY;

ANIMALIA;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; PLASMINOGEN ACTIVATORS; RECEPTORS, CELL SURFACE; RNA STABILITY; RNA, MESSENGER; URINARY PLASMINOGEN ACTIVATOR;

EID: 0036005959     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2002.005     Document Type: Review

References (79)

1. Inhibition of protein synthesis in LLC-PKI cells increases calcitonin-induced plasminogen-activator gene transcription and mRNA stability
2. Cloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitor
3. Degradation of mRNA in eukaryotes
4. Control of c-myc mRNA half-life in vitro by a protein capable of binding to a coding region stability determinant
5. The urokinase receptor. A cell surface, regulated chemokine
6. Urokinase-type plasminogen activator: Proenzyme, receptor, and inhibitors
7. Assignment of the urokinase-type plasminogen activator receptor gene (PLAUR) to chromosome 19q13.1-q13.2
8. Human plasminogen activator inhibitor-1 gene. Promoter and structural gene nucleotide sequences
9. Different induction of two plasminogen activator inhibitor 1 mRNA species by phorbol ester in human hepatoma cells
10. Isolation and characterization of the rat plasminogen activator, inhibitor-1 gene
11. Multiple functions for the poly(A)-binding protein in mRNA decapping and deadenylation in yeast
12. Iron regulation of transferrin receptor mRNA levels requires iron-responsive elements and a rapid turnover determinant in the 3′ untranslated region of the mRNA
13. The structure of the urokinase-type plasminogen activator receptor gene
14. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration
15. AU-rich elements: Characterization and importance in mRNA degradation
16. The 3′ untranslated region of messenger RNA: A molecular 'hotspot' for pathology?
17. Interaction of polyadenylate-binding protein with the elF4G homologue PAIP enhances translation
18. Sodium butyrate inhibits expression of urokinase and its receptor mRNAs at both transcription and post-transcription levels in colon cancer cells
19. Plasminogen activators, tissue degradation, and cancer
20. The murine urokinase-type plasminogen activator gene
21. Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements
22. Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis: Evidence for an alternate biological function
23. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs
24. Post-transcriptional regulation of expression of plasminogen activator inhibitor type 1 mRNA by insulin and insulin-like growth factor 1
25. The inhibitory effect of the 5′ untranslated region of muscle acylphosphatase mRNA on protein expression is relieved during cell differentiation
26. cDNA cloning of human plasminogen activator-inhibitor from endothelial cells
27. A mechanism for translationally coupled mRNA turnover: Interaction between the poly(A) tail and a c-fos RNA coding determinant via a protein complex
28. Transcriptional and post-transcriptional regulation of urokinase-type plasminogen activator expression in endothelial cells by basic fibroblast growth factor
29. Transcriptional and posttranscriptional regulation of type 1 plasminogen activator inhibitor and tissue-type plasminogen activator gene expression in HTC rat hepatoma cells by glucocorticoids and cyclic nucleotides
30. Cyclic nucleotide regulation of type-1 plasminogen activator-inhibitor mRNA stability in rat hepatoma cells: Identification of cis-acting sequences
31. Identification and cDNA cloning of a novel RNA-binding protein that interacts with the cyclic nucleotide-responsive sequence in the Type-1 plasminogen activator inhibitor mRNA
32. Post-transcriptional regulation of urokinase plasminogen activator gene expression occurs in the nucleus of BC1 rat mammary tumor cells
33. Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38α mitogen-activated protein kinase activity
34. The plasminogen activator system: Biology and regulation
35. Purification and characterization of cytosolic aconitase from beef liver and its relationship to the iron-responsive element binding protein
36. Poly(A) tail shortening by a mammalian poly(A)-specific 3′-exoribonuclease
37. AUUUA is not sufficient to promote poly(A) shortening and degradation of an mRNA: The functional sequence within AU-rich elements may be UUAUUUA(U/A)(U/A)
38. Activation of the transforming potential of the human fos proto-oncogene requires message stabilization and results in increased amounts of partially modified fos protein
39. Structure of the human plasminogen activator inhibitor 1 gene: Nonrandom distribution of introns
40. Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell line A549
41. Both increased stability and transcription contribute to the induction of the urokinase plasminogen activator receptor (uPAR) message by hypoxia
42. Plasminogen activator inhibitor type 2 gene induction by tumor necrosis factor and phorbol ester involves transcriptional and post-transcriptional events: Identification of a functional nonameric the 3′-untranslated region
43. An AU-rich sequence in the 3′-UTR of plasminogen activator inhibitor type 2 (PAI-2) mRNA promotes PAI-2 mRNA decay and provides a binding site for nuclear HuR
44. cDNA and gene nucleotide sequence of porcine plasminogen activator
45. Structure, and function of the urokinase-type plasminogen activator gene
46. AUH, a gene encoding an AU-specific RNA binding protein with intrinsic enoyl-CoA hydratase activity
47. Multiple instability-regulating sites in the 3′ untranslated region of the urokinase-type plasminogen activator mRNA
48. Enhanced stability of urokinase-type plasminogen activator mRNA in metastatic breast cancer MDA-MB-231 cells and LLC-PK 1 cells down-regulated for protein kinase C-correlation with cytoplasmic heterogeneous nuclear ribonucleoprotein C
49. Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor
50. Urokinase-receptor and integrin partnership: Coordination of signaling for cell adhesion, migration and growth
51. The c-myc-regulated gene mrl encodes plasminogen activator inhibitor 1
52. Modulation of granulocyte-macrophage colony-stimulating factor mRNA stability in vitro by the adenosine-uridine binding factor
53. Removal of an mRNA destabilizing element correlates with the increased oncogenicity of proto-oncogene fos
54. The human urokinase-plasminogen activator gene and its promoter
55. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis
56. mRNA stability in mammalian cells
57. 5′ untranslated sequences modulate rapid mRNA degradation mediated by 3′ AU-rich element in v-/c-fos recombinants
58. Evidence for instability of mRNAs containing AUUUA motifs mediated through translation-dependent assembly of a > 20S degradation complex
59. Multiple elements in the c-fos protein-coding region facilitate mRNA deadenylation and decay by a mechanism coupled to translation
60. Post-transcriptional regulation of urokinase mRNA. Identification of a novel urokinase mRNA-binding protein in human lung epithelial cells in vitro
61. Posttranscriptional regulation of urokinase receptor mRNA identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells
62. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces binding of a 50 kDa protein on the 3′ untranslated region of urokinase-type plasminogen activator mRNA
63. Two distinct destabilizing elements in the c-fos message trigger deadenylation as a first step in rapid mRNA decay
64. The murine urokinase-type plasminogen activator receptor gene
65. Plasminogen activator inhibitor type 2 contains mRNA instability elements within exon 4 of the coding region. Sequence homology to coding region instability determinants in other mRNAs
66. Cyclic nucleotide regulation of PAI-1 mRNA stability: Identification of cytosolic proteins that interact with an A-rich sequence
67. The plasminogen activator/plasmin system
68. Post-termination ribosome interactions with the 5′UTR modulate yeast mRNA stability
69. Posttranscriptional regulation of urokinase plasminogen activator receptor messenger RNA levels by leukocyte integrin engagement
70. Post-transcriptional regulation of the gli1 oncogene by the expression of alternative 5′ untranslated regions
71. Identification of the urokinase receptor as an adhesion receptor for vitronectin
72. Multiple transforming growth factor-β-inducible elements regulate expression of the plasminogen activator inhibitor type-1 gene in Hep G2 cells
73. The protein-coding region of c-myc mRNA contains a sequence that specifies rapid mRNA turnover and induction by protein synthesis inhibitors
74. Expression of dioxin-responsive genes in human endometrial cells in culture
75. Structure of the gene for human plasminogen activator inhibitor-2: The nearest mammalian homologue of chicken ovalbumin
76. Regulation of expression of plasminogen activator inhibitor-1, in cultured rat osteoblastic cells by osteogenic protein-1 (BMP-7)
77. Autoregulated instability of β-tubulin mRNAs by recognition of the nascent amino terminus of β-tubulin
78. Protein kinase C down-regulation enhances cAMP-mediated induction of urokinase-type plasminogen activator mRNA in LLC-PK1 cells
79. The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation